* Says multiple site study is expected to enroll 148
subjects with T2DM
The post BRIEF-Ligand says initiates phase 2 trial with LGD-6972 appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Says multiple site study is expected to enroll 148
subjects with T2DM
The post BRIEF-Ligand says initiates phase 2 trial with LGD-6972 appeared first on NASDAQ.